FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES. CMN [Internet]. 2024 Nov. 12 [cited 2025 Jun. 13];6(2):7092-101. Available from: http://cahiersmagellanes.com/index.php/CMN/article/view/1040